Prostate Cancer Risk Calculator

Prostate Cancer Risk Calculator for Oncology. The three outcomes concern biopsy detection: no cancer, Gleason below 7 and Gleason at least 7. They are not lifetime incidence, stage or survival. The site does not impose a percentage at which biopsy is automatically recommended. Display rounding is separate from the probability calculation.

For shared guidance on choosing a tool and documenting results, read the clinical calculator workflow.

How this calculator works

PCPT 2.0 uses two logits relative to no cancer. With P = log2(PSA), A = age, R = original African American indicator, B = prior negative biopsy, D = suspicious DRE and F = first-degree family history: L = -3.00215469 + 0.25613390P + 0.01643637A + 0.12172599R - 0.45533257B - 0.03864628D + 0.27197219F. H = -7.05304534 + 0.70489441P + 0.04753804A + 1.04174529R - 0.21409933B + 0.40068434D + 0.22467348F. Divide 1, exp(L) and exp(H) by their sum, then multiply by 100.

When to use this calculator

An explicitly historical base-model estimate of findings if biopsy were performed, in a person without previous prostate cancer and with recent PSA/DRE. This local version requires all six model predictors. It is not a recommendation to start PSA screening.

Inputs used

  • Age in years: implementation restricted to the reported 55-91 cohort range
  • PSA in ng/mL: greater than zero and no higher than 10 in this base-model implementation
  • Prior cancer diagnosis and confirmation that PSA/DRE are from the past year
  • Original model African American category, assessed DRE and prior negative biopsy
  • Prostate cancer in a biological father, brother or son, explicitly assessed

Clinical interpretation

The three outcomes concern biopsy detection: no cancer, Gleason below 7 and Gleason at least 7. They are not lifetime incidence, stage or survival. The site does not impose a percentage at which biopsy is automatically recommended. Display rounding is separate from the probability calculation.

Worked example

Using the publication's illustrative 55-year-old with PSA 3.8 ng/mL, a previous negative biopsy, normal DRE and no first-degree family history, in the original non-African-American category, the full-precision coefficients yield 85.8736% no cancer, 10.9430% low-grade and 3.1834% high-grade findings. The low/high results agree with the article's rounded 11% and 3% example.

Limitations and safety notes

This independently written base-model implementation excludes optional percent-free PSA, detailed family history and SNP updates, as well as MRI. PSA is capped at 10 to match the study's development inclusion, although the official interface accepts a wider range. Development data largely involved White men and six-core biopsy; accuracy may differ elsewhere. The age bounds are an implementation restriction, not an accuracy guarantee or independent clinical validation.

References

  • PCPT. Original risk calculator, model scope and input definitions. https://riskcalc.org/PCPTRC/
  • Ankerst DP et al. PCPT Risk Calculator 2.0 for low- versus high-grade prostate cancer. Urology 2014. https://pmc.ncbi.nlm.nih.gov/articles/PMC4035700/
  • Cleveland Clinic QHS. Officially linked PCPTRC riskcalc.R, complete six-variable branch. https://github.com/ClevelandClinicQHS/riskcalc-website/blob/main/PCPTRC/riskcalc.R

Editorial review and citation methodology

Maintained by the Quick Medical Calculator Editorial Team. Content record date: September 9, 2026. A content date is not evidence of independent clinical review. Individual clinical sign-off is not recorded on this page.

  • Prefer original validation studies for scoring systems and prediction tools.
  • Use current specialty society guidance, transplant allocation policy, public health guidance, or regulator resources when they govern clinical use.
  • Include limitations and safety notes when a calculator is population-specific, context-dependent, or unsuitable as a standalone decision tool.

Related reviewed calculators